XENPOZYME

This brand name is authorized in Austria, Croatia, France, Israel, Italy, Japan, Lithuania, Romania.

Active ingredients

The drug XENPOZYME contains one active pharmaceutical ingredient (API):

1	Olipudase alfa UNII 6D5766Q4OP - OLIPUDASE ALFA
	Olipudase alfa is a recombinant human acid sphingomyelinase that reduces sphingomyelin (SM) accumulation in organs of patients with Acid Sphingomyelinase Deficiency (ASMD).
	Read more about Olipudase alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
XENPOZYME Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AB	Enzymes	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products
Discover more medicines within A16AB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	63908675
IL	מִשְׂרַד הַבְּרִיאוּת	9277
IT	Agenzia del Farmaco	050121019, 050121021, 050121033, 050121045, 050121058, 050121060, 050121072
JP	医薬品医療機器総合機構	3959426D1022
LT	Valstybinė vaistų kontrolės tarnyba	1095026, 1095027, 1095028, 1095029
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68945001, W68945002